InvestorsHub Logo
Followers 61
Posts 6994
Boards Moderated 0
Alias Born 10/03/2004

Re: abuhafsa post# 2187

Wednesday, 01/16/2019 10:12:15 AM

Wednesday, January 16, 2019 10:12:15 AM

Post# of 2296
I also popped in here for the same reason. Quickly scanning the intro leaves me with a big question. It says lead Phase 3 candidate Eravracycline was being submitted for U.S. Regulatory approval in 2015. So, where is the update? Have they not updated their website/ board intro the last 4-5 years or was the submission not accepted?